Oguzhan Alagoz
Oguzhan Alagoz
Proctor & Gamble Bascom Professor, University of Wisconsin-Madison
Потвърден имейл адрес: engr.wisc.edu - Начална страница
State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3
U Siebert, O Alagoz, AM Bayoumi, B Jahn, DK Owens, DJ Cohen, ...
Medical Decision Making 32 (5), 690-700, 2012
Markov decision processes: a tool for sequential decision making under uncertainty
O Alagoz, H Hsu, AJ Schaefer, MS Roberts
Medical Decision Making 30 (4), 474-483, 2010
Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012
SK Plevritis, D Munoz, AW Kurian, NK Stout, O Alagoz, AM Near, SJ Lee, ...
Jama 319 (2), 154-164, 2018
Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies
JS Mandelblatt, NK Stout, CB Schechter, JJ Van Den Broek, DL Miglioretti, ...
Annals of internal medicine 164 (4), 215-225, 2016
The optimal timing of living-donor liver transplantation
O Alagoz, LM Maillart, AJ Schaefer, MS Roberts
Management Science 50 (10), 1420-1430, 2004
Modeling secrecy and deception in a multiple-period attacker–defender signaling game
J Zhuang, VM Bier, O Alagoz
European Journal of Operational Research 203 (2), 409-418, 2010
OR Forum—A POMDP approach to personalize mammography screening decisions
T Ayer, O Alagoz, NK Stout
Operations research 60 (5), 1019-1034, 2012
Comparison of logistic regression and artificial neural network models in breast cancer risk estimation
T Ayer, J Chhatwal, O Alagoz, CE Kahn Jr, RW Woods, ES Burnside
Radiographics 30 (1), 13-22, 2010
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts
BL Sprague, NK Stout, C Schechter, NT Van Ravesteyn, M Cevik, ...
Annals of internal medicine 162 (3), 157-166, 2015
Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration
T Ayer, O Alagoz, J Chhatwal, JW Shavlik, CE Kahn Jr, ES Burnside
Cancer 116 (14), 3310-3321, 2010
Determining the acceptance of cadaveric livers using an implicit model of the waiting list
O Alagoz, LM Maillart, AJ Schaefer, MS Roberts
Operations Research 55 (1), 24-36, 2007
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality
D Munoz, AM Near, NT Van Ravesteyn, SJ Lee, CB Schechter, O Alagoz, ...
Journal of the National Cancer Institute 106 (11), dju289, 2014
Optimal breast biopsy decision-making based on mammographic features and demographic factors
J Chhatwal, O Alagoz, ES Burnside
Operations research 58 (6), 1577-1591, 2010
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography
NK Stout, SJ Lee, CB Schechter, K Kerlikowske, O Alagoz, D Berry, ...
Journal of the National Cancer Institute 106 (6), dju092, 2014
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk
NT Van Ravesteyn, DL Miglioretti, NK Stout, SJ Lee, CB Schechter, ...
Annals of internal medicine 156 (9), 609-617, 2012
A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process
SM Shechter, CL Bryce, O Alagoz, JE Kreke, JE Stahl, AJ Schaefer, ...
Medical Decision Making 25 (2), 199-209, 2005
A survey of optimization models on cancer chemotherapy treatment planning
J Shi, O Alagoz, FS Erenay, Q Su
Annals of Operations Research 221, 331-356, 2014
Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts
CI Lee, M Cevik, O Alagoz, BL Sprague, ANA Tosteson, DL Miglioretti, ...
Radiology 274 (3), 772-780, 2015
Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling
O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ...
JNCI: Journal of the National Cancer Institute 113 (11), 1484-1494, 2021
Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes
A Trentham-Dietz, K Kerlikowske, NK Stout, DL Miglioretti, CB Schechter, ...
Annals of internal medicine 165 (10), 700-712, 2016
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20